Related Experiment Video
Updated: Apr 27, 2026

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
Value of expression of insulin-like growth factor-1 receptor in gastric adenocarcinomas and normal gastric tissues
Ömer Topalak1, Funda Uğur Kantar, Çağnur Ulukuş
1Department of Gastroenterology, Dokuz Eylül University Faculty of Medicine, İzmir, Turkey. fundaugurkantar@yahoo.com.
Background/Aims:
Insulin-like growth factor-1 receptor (IGF-1R) plays critical roles in cell proliferation, differentiation, apoptosis, and transformation. Suppression of IGF-1R by means of antisense methods and specific antibodies causes cell apoptosis and growth inhibition of cancer cells. The present study aims to investigate whether there is a difference between normal and cancerous tissue with respect to IGF-1R expression and to assess the relationship between IGF-1R expression and tumor stage, degree of differentiation, and lymph node metastasis by examining IGF-1R expression in cancerous and normal tissues of gastric adenocarcinoma cases of different stages.
Materials And Methods:
By using immunohistochemical methods, IGF-1Rb (H-60) (1/100, Santa Cruz Biotechnology, SC-9038, Texas,USA) expression was investigated in paraffin-embedded blocks obtained from total/partial gastrectomy material pertaining to 47 gastric adenocarcinoma cases. IGF-1R expression was evaluated semi-quantitatively in terms of intensity and distribution in both normal and cancerous tissues.
Results:
Insulin-like growth factor-1 receptor expression mean score was 5.38 and 8.40 for cancerous and for normal gastric tissues, respectively. IGF-1R expression decreased significantly in cancerous tissues compared normal tissue (p:0.001). When all cases with and without lymph node metastasis were analyzed, IGF-1R expression was observed to decrease for cases with lymph node metastasis compared to those without lymph node metastasis (p:0.035).
Conclusion:
Insulin-like growth factor-1 receptor expression in gastric cancer tissue has proven to be considerably lower than IGF-1R expression in normal gastric mucosa. Metastatic progression reduces IGF-1R expression gradually in cancer tissue.
Insights
Insulin-like growth factor-1 receptor (IGF-1R) expression is significantly lower in gastric cancer tissues compared to normal tissues. This decreased IGF-1R expression correlates with lymph node metastasis, suggesting its role in gastric adenocarcinoma progression.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Insulin-like growth factor-1 receptor (IGF-1R) is crucial for cell growth and survival.
- IGF-1R targeted therapies show promise in inhibiting cancer cell proliferation and inducing apoptosis.
- Understanding IGF-1R expression in gastric adenocarcinoma is vital for developing targeted treatment strategies.
Purpose of the Study:
- To compare IGF-1R expression levels between normal gastric mucosa and gastric adenocarcinoma tissues.
- To investigate the correlation between IGF-1R expression and clinicopathological features such as tumor stage, differentiation, and lymph node metastasis in gastric cancer.
Main Methods:
- Immunohistochemical analysis was employed to evaluate IGF-1R expression.
- Expression levels were assessed semi-quantitatively in 47 gastric adenocarcinoma cases.
- Paraffin-embedded tissues from normal and cancerous gastric specimens were utilized.
Main Results:
- IGF-1R expression was significantly lower in cancerous gastric tissues (mean score 5.38) compared to normal tissues (mean score 8.40) (p<0.001).
- A significant decrease in IGF-1R expression was observed in gastric cancer cases with lymph node metastasis compared to those without (p=0.035).
Conclusions:
- Gastric adenocarcinoma tissues exhibit markedly reduced IGF-1R expression compared to normal gastric mucosa.
- Metastatic progression in gastric cancer is associated with a gradual decline in IGF-1R expression.
Related Concept Videos
Mitogens and the Cell Cycle
Gastritis II: Pathophysiology
Insulin: The Receptor and Signaling Pathways

